Home Authors Posts by The Motley Fool

The Motley Fool

195 POSTS 0 COMMENTS
- Advertisement -

Recent Posts

Most Popular

village-farms-international-vff-reports-wider-loss-for-q3-on-lower-sales-stock-falls

Village Farms International (VFF) reports wider loss for Q3 on lower sales; stock falls

Village Farms International, Inc. (NASDAQ: VFF) reported a wider net loss for the third quarter of 2019, reversing the positive momentum seen since the beginning of the year, due to a decline in produce sales and increase in expenses. The company’s stock closed Thursday’s regular trading at $6.80, down 4%. The Canada-based Greenhouse vegetable producer…
cormedix-inc.-nyse-crmd-q3-2019-earnings-snapshot

CorMedix, Inc. (NYSE: CRMD): Q3 2019 Earnings Snapshot

— CorMedix, Inc. (NYSE: CRMD) reported a net loss attributable to common shareholders of $32.4 million or $1.35 per share for the third quarter, compared to a loss of $10.2 million or $0.54 per share last year. Analysts estimated a loss of $0.25 per share — Net sales dropped to $59 thousand from $372 thousand…
aurinia-pharmaceuticals-nasdaq-auph-q3-2019-earnings-snapshot

Aurinia Pharmaceuticals (NASDAQ: AUPH): Q3 2019 Earnings Snapshot

— Aurinia Pharmaceuticals (NASDAQ: AUPH) reported a third-quarter 2019 loss of $0.21 per share versus a loss of $0.15 per share expected. — Revenue plunged by 39% to $230,000 versus $50,000 expected. The top line was hurt by nil contract revenue. — Research and development expenses soared by 59% due to the manufacturing of voclosporin…
applied-materials-inc.-nasdaq-amat-q4-2019-earnings-snapshot

Applied Materials, Inc. (NASDAQ: AMAT): Q4 2019 Earnings Snapshot

— Applied Materials, Inc. (NASDAQ: AMAT)reported adjusted earnings of $0.80 per share for the fourth quarter of 2019, vs. $0.76 per share expected. — Net income, on an unadjusted basis, dropped to $698 million or $0.75 per share from $757 million or $0.77 per share last year — Net sales were broadly flat at $3.75…
titan-pharmaceuticals-ttnp-q3-2019-earnings-snapshot

Titan Pharmaceuticals (TTNP): Q3 2019 Earnings Snapshot

— Titan Pharmaceuticals (NASDAQ: TTNP) reported Q3 2019 loss of $0.18 per share, vs. $0.21 expected. — Revenues fell 47% to approx. $0.9 million, vs. $0.7 million expected. — Product revenues totaled approx. $0.2 million. — Grant revenues totaled approx. $0.8 million. — R&D expenses amounted to approx. $1.6 million. — TTNP shares gained 1%…